'Inflationary Pressures Continue To Impact" Cannabis Industry, Says C21 As It Reports Net Loss And Decline In Nevada Sales
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 16 2024
0mins
Source: Benzinga
Financial Performance: C21 Investments reported a revenue of $6.6 million for the first quarter ending June 30, 2023, marking a slight increase despite a 1% decline in Nevada sales, with gross margins affected by inventory issues related to the launch of a new dispensary.
Operational Highlights: The company experienced a net loss of $1.4 million but maintained positive cash flow from operations and completed the acquisition of a third dispensary, which was rebranded and became operational at the end of the quarter.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





